Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05201833 · ClinicalTrials.gov registry record
TRACK-TBI Longitudinal Biomarker Study
A clinical trial of Traumatic Brain Injury, sponsored by University of Pennsylvania.
- Active
- Registry status
- 300
- Enrollment target
- 11
- Study locations
NCT05201833: Active study of Traumatic Brain Injury, sponsored by University of Pennsylvania.
NCT05201833 is a study of Traumatic Brain Injury that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 300 participants, roughly in line with the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target. The trial reports 11 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05201833, a study of Traumatic Brain Injury, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 11
- Study locations
Study Summary
The overarching goal of this study is to improve understanding of the long-range natural history of TBI by extending follow-up of a previously enrolled cohort (TRACK-TBI) beyond the first 12 months after injury.
Primary Outcome
The GOSE provides an overall measure of functional status based on information on cognition, independence, employability, and social/community participation collected via structured interview. Individuals are described by one of the eight outcome categories: Dead (1); Vegetative State (2); Lower Severe Disability (3); Upper Severe Disability (4); Lower Moderate Disability (5); Upper Moderate Disability (6); Lower Good Recovery (7) and Upper Good Recovery (8). Good Recovery is defined as a score
Conditions Studied
Interventions
- PROCEDURE Blood Draw
- BEHAVIORAL In-Person Outcome Assessment
- PROCEDURE 3T Magnetic Resonance Imaging (MRI)
- BEHAVIORAL Telephone Outcome Assessment
Study Locations (11)
Texas
- University of Texas at Austin - Austin
- University of Texas Southwestern - Dallas
- Baylor College of Medicine - Houston
Pennsylvania
- University of Pennsylvania/Penn Presbyterian Medical Center - Philadelphia
- University of Pittsburgh - Pittsburgh
California
- University of California, San Francisco - San Francisco
Massachusetts
- Spaulding Rehabilitation Hospital - Charlestown
Ohio
- University of Cincinnati - Cincinnati
Utah
- University of Utah - Salt Lake City
Virginia
- Virginia Commonwealth University - Richmond
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2027-02-28 |
What the registry record for NCT05201833 still lists
NCT05201833 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target.
The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 4 interventions - of which Blood Draw is the first listed.
NCT05201833 lists 11 locations in 8 states (Texas, Pennsylvania, California).
Frequently Asked Questions
What is clinical trial NCT05201833 about?
NCT05201833 is a clinical study titled "TRACK-TBI Longitudinal Biomarker Study". The overarching goal of this study is to improve understanding of the long-range natural history of TBI by extending follow-up of a previously enrolled cohort (TRACK-TBI) beyond the first 12 months after injury.
What is the current status of trial NCT05201833?
This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2022-03-01. Estimated completion is 2027-02-28.
What conditions does trial NCT05201833 study?
This clinical trial studies the following conditions: Traumatic Brain Injury.
What interventions are being tested in trial NCT05201833?
The interventions under investigation include: Blood Draw (PROCEDURE), In-Person Outcome Assessment (BEHAVIORAL), 3T Magnetic Resonance Imaging (MRI) (PROCEDURE), Telephone Outcome Assessment (BEHAVIORAL).
Who is sponsoring clinical trial NCT05201833?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05201833 being conducted?
This trial has 11 study locations across California, Massachusetts, Ohio, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05201833's enrollment target sits among peer trials
300 20th of 171 higher than 146 of 171 other Traumatic Brain Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
tPBM in Older Adults With Traumatic Brain Injury
RECRUITING · NA
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
RECRUITING · Phase 1
-
Carbon Dioxide Administration and Brain Waste Clearance
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Cortical Spreading Depolarization After Severe Traumatic Brain Injury
RECRUITING
-
A Study to Evaluate the SENSE Device's Ability to Detect TBI
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI